CLOSALIS 50 micrograms/0.5 mg/g, gel tube, 60 g
Active ingredients: Betamethasone, Calcipotriol, Calcipotriene hydrate, Betamethasone dipropionate
Commercialized according to BDPMDispensing in France: Prescription only
Geltube, 60 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLOSALIS 50 microgrammes/0,5 mg/g, gel
- Pharmaceutical form
- gel
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) polyéthylène haute densité (PEHD) de 60 g
- Marketing authorisation holder
- LABORATOIRES MEDGEN
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65019468CIP73023060CIP133400930230602Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEgel | 0,5 mg · 1 g de gel | FT |
| DIPROPIONATE DE BÉTAMÉTHASONEgel | — | SA |
| CALCIPOTRIOLgel | 50 microgrammes · 1 g de gel | FT |
| CALCIPOTRIOL MONOHYDRATÉgel | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.